PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
60 hedge funds and large institutions have $131M invested in Provention Bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% more funds holding
Funds holding: 48 → 60 (+12)
Holders
60
Holding in Top 10
1
Calls
$3.75M
Puts
$1.79M
Top Buyers
| 1 | +$33.6M | |
| 2 | +$2.59M | |
| 3 | +$2.36M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$2.28M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.23M |
Top Sellers
| 1 | -$6.9M | |
| 2 | -$4.95M | |
| 3 | -$2.94M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$1.98M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$1.7M |